129 related articles for article (PubMed ID: 17428798)
1. Solution structure of human secretory component and implications for biological function.
Bonner A; Perrier C; Corthésy B; Perkins SJ
J Biol Chem; 2007 Jun; 282(23):16969-80. PubMed ID: 17428798
[TBL] [Abstract][Full Text] [Related]
2. Functional and structural characterisation of human colostrum free secretory component.
Almogren A; Bonner A; Perkins SJ; Kerr MA
Mol Immunol; 2009 Apr; 46(7):1534-41. PubMed ID: 19230975
[TBL] [Abstract][Full Text] [Related]
3. Role of J chain in secretory immunoglobulin formation.
Johansen FE; Braathen R; Brandtzaeg P
Scand J Immunol; 2000 Sep; 52(3):240-8. PubMed ID: 10972899
[TBL] [Abstract][Full Text] [Related]
4. The structure and dynamics of secretory component and its interactions with polymeric immunoglobulins.
Stadtmueller BM; Huey-Tubman KE; López CJ; Yang Z; Hubbell WL; Bjorkman PJ
Elife; 2016 Mar; 5():. PubMed ID: 26943617
[TBL] [Abstract][Full Text] [Related]
5. Biophysical and Biochemical Characterization of Avian Secretory Component Provides Structural Insights into the Evolution of the Polymeric Ig Receptor.
Stadtmueller BM; Yang Z; Huey-Tubman KE; Roberts-Mataric H; Hubbell WL; Bjorkman PJ
J Immunol; 2016 Aug; 197(4):1408-14. PubMed ID: 27412418
[TBL] [Abstract][Full Text] [Related]
6. Extended flexible linker structures in the complement chimaeric conjugate CR2-Ig by scattering, analytical ultracentrifugation and constrained modelling: implications for function and therapy.
Gilbert HE; Aslam M; Guthridge JM; Holers VM; Perkins SJ
J Mol Biol; 2006 Feb; 356(2):397-412. PubMed ID: 16375923
[TBL] [Abstract][Full Text] [Related]
7. Probing the topography of free and polymeric Ig-bound human secretory component with monoclonal antibodies.
Bakos MA; Kurosky A; Woodard CS; Denney RM; Goldblum RM
J Immunol; 1991 Jan; 146(1):162-8. PubMed ID: 1701790
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a critical binding site for human polymeric Ig on secretory component.
Bakos MA; Kurosky A; Goldblum RM
J Immunol; 1991 Nov; 147(10):3419-26. PubMed ID: 1940346
[TBL] [Abstract][Full Text] [Related]
9. Solution structure of the complex between CR2 SCR 1-2 and C3d of human complement: an X-ray scattering and sedimentation modelling study.
Gilbert HE; Eaton JT; Hannan JP; Holers VM; Perkins SJ
J Mol Biol; 2005 Feb; 346(3):859-73. PubMed ID: 15713468
[TBL] [Abstract][Full Text] [Related]
10. Implications of the near-planar solution structure of human myeloma dimeric IgA1 for mucosal immunity and IgA nephropathy.
Bonner A; Furtado PB; Almogren A; Kerr MA; Perkins SJ
J Immunol; 2008 Jan; 180(2):1008-18. PubMed ID: 18178841
[TBL] [Abstract][Full Text] [Related]
11. Extended and flexible domain solution structure of the extracellular matrix protein anosmin-1 by X-ray scattering, analytical ultracentrifugation and constrained modelling.
Hu Y; Sun Z; Eaton JT; Bouloux PM; Perkins SJ
J Mol Biol; 2005 Jul; 350(3):553-70. PubMed ID: 15949815
[TBL] [Abstract][Full Text] [Related]
12. The extended multidomain solution structures of the complement protein Crry and its chimeric conjugate Crry-Ig by scattering, analytical ultracentrifugation and constrained modelling: implications for function and therapy.
Aslam M; Guthridge JM; Hack BK; Quigg RJ; Holers VM; Perkins SJ
J Mol Biol; 2003 Jun; 329(3):525-50. PubMed ID: 12767833
[TBL] [Abstract][Full Text] [Related]
13. The J chain is essential for polymeric Ig receptor-mediated epithelial transport of IgA.
Johansen FE; Braathen R; Brandtzaeg P
J Immunol; 2001 Nov; 167(9):5185-92. PubMed ID: 11673531
[TBL] [Abstract][Full Text] [Related]
14. A conserved binding site on the receptor for polymeric Ig is homologous to CDR1 of Ig V kappa domains.
Bakos MA; Kurosky A; Czerwinski EW; Goldblum RM
J Immunol; 1993 Aug; 151(3):1346-52. PubMed ID: 8335931
[TBL] [Abstract][Full Text] [Related]
15. Lack of SC/pIgR-mediated epithelial transport of a human polymeric IgA devoid of J chain: in vitro and in vivo studies.
Vaerman JP; Langendries A; Giffroy D; Brandtzaeg P; Kobayashi K
Immunology; 1998 Sep; 95(1):90-6. PubMed ID: 9767462
[TBL] [Abstract][Full Text] [Related]
16. The structure of bovine secretory component.
Beale D
Vet Immunol Immunopathol; 1987 Dec; 17(1-4):37-49. PubMed ID: 3433666
[TBL] [Abstract][Full Text] [Related]
17. In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA.
Renegar KB; Jackson GD; Mestecky J
J Immunol; 1998 Feb; 160(3):1219-23. PubMed ID: 9570537
[TBL] [Abstract][Full Text] [Related]
18. Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo.
Phalipon A; Cardona A; Kraehenbuhl JP; Edelman L; Sansonetti PJ; Corthésy B
Immunity; 2002 Jul; 17(1):107-15. PubMed ID: 12150896
[TBL] [Abstract][Full Text] [Related]
19. Secretory component delays the conversion of secretory IgA into antigen-binding competent F(ab')2: a possible implication for mucosal defense.
Crottet P; Corthésy B
J Immunol; 1998 Nov; 161(10):5445-53. PubMed ID: 9820520
[TBL] [Abstract][Full Text] [Related]
20. Solution structure determination of monomeric human IgA2 by X-ray and neutron scattering, analytical ultracentrifugation and constrained modelling: a comparison with monomeric human IgA1.
Furtado PB; Whitty PW; Robertson A; Eaton JT; Almogren A; Kerr MA; Woof JM; Perkins SJ
J Mol Biol; 2004 May; 338(5):921-41. PubMed ID: 15111057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
